20
Participants
Start Date
April 19, 2024
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
Ruxolitinib 1.5% cream
Topical application of Ruxolitinib 1.5% cream
Application without occlusion in Area 1
Apply Ruxolitinib 1.5% cream on the discoid lupus erythematosus lesion without occlusion on Area 1.
Application under occlusion at night in Area 2
Apply Ruxolitinib 1.5% cream on the discoid lupus erythematosus lesion under occlusion at night on Area 2.
Application under occlusion at night in Area 1
Apply Ruxolitinib 1.5% cream on the discoid lupus erythematosus lesion under occlusion at night on Area 1.
Application without occlusion in Area 2
Apply Ruxolitinib 1.5% cream on the discoid lupus erythematosus lesion without occlusion on Area 2.
RECRUITING
INNO-6051 Site 03, Fredericton
RECRUITING
Innovaderm Research Inc., Montreal
Lead Sponsor
Innovaderm Research Inc.
OTHER